Latest Platform Expansion News

Freelancer Limited has reported a landmark FY25 with record net profit and revenue growth, powered by strong AI integration and strategic expansion across its core marketplaces.

Butn Limited has reported its fifth consecutive half-year of revenue growth, underpinned by a $100 million senior debt facility and expanding platform originations. Despite a statutory loss, the company’s operational momentum and strategic initiatives signal robust growth prospects.

Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.

Viva Leisure has reported a striking 168% jump in net profit after tax for HY2026, driven by strong revenue growth and a booming technology segment. The company’s strategic shift towards technology and network optimisation is paying off, with cash flow and membership numbers also on the rise.

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.

Praemium Limited reported a 14% year-on-year increase in total Funds Under Administration to $70.5 billion for Q2 FY26, completing the OneVue transition and seeing strong net inflows in its Spectrum and Powerwrap platforms.

Control Bionics Limited is set to acquire the remaining stake in Neuro Elite Athletics, integrating the NeuroBounce athletic performance program with its EMG technology to accelerate growth in key markets.

BetMakers Technology Group has secured a favorable three-year content distribution agreement with Penn Entertainment, alongside strong digital customer growth that signals robust momentum for FY26 and beyond.

Vinyl Group Ltd has reported a striking 190% revenue increase in FY25, driven by strategic acquisitions and organic growth, and is targeting its first profitable quarter by December 2025 with AI-powered publishing expansion.

Infragreen Group Limited has reported a strong FY25 performance, exceeding prospectus forecasts with $18.6 million in pro forma EBITDA and a successful $40 million IPO. The company projects robust growth in FY26, driven by organic expansion and strategic acquisitions in sustainable infrastructure.

Assetora Limited has raised $2 million through a private placement with CardioLink Pty Ltd, aiming to fuel its platform expansion and product development.

Assetora Limited has reopened its flagship fund under a new name, secured a $3 million strategic investment, and reported its first positive operating cashflow since adopting its fund-management model.